CDC42 and androgen insensitivity syndrome: Considering the role of CDC42 on thrombosis and as a protective factor in AIS; therefore, CDC42 slightly decreased within 3 days and then exhibited a climbing trend from 3 days to 3 years in patients with AIS (23).